Close
FINDING CURES TOGETHER<sup>SM</sup>

​​Radiation Science and Medicine ​Working Group Programs and Initiatives

Targeting the Tumor Microenvironment in Radiation Oncology

July 26-27, 2018
FHI 360 Conference Center
Washington, DC

Presented by the American Society for Radiation Oncology (ASTRO) in collaboration with the AACR Radiation Science and Medicine Working Group

AACR/ASCO Methods in Clinical Cancer Research Workshop

July 28-Aug. 3, 2018
Vail Mountain Marriott Resort
Vail, Colorado

Application Submission Deadline: Monday, March 12, 2018, 11:59 p.m. ET

An intensive workshop in the essentials of effective clinical trial designs of therapeutic interventions in the treatment of cancer for clinical fellow and junior faculty clinical researchers in all oncology subspecialties, including radiation and surgical oncology and radiology.

Supported by the National Cancer Institute of the National Institutes of Health under Award Number R25CA068647. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
This activity is supported by educational grants from AbbVie, Inc., Amgen, Astellas, Celgene Corporation, Lilly, and Pfizer.
Educational Grant provided by ASTRO.

Apply Now (login required)


Past Programs

Radiation Researc​​​​h Society-AACR Workshop
Targeting Cancer Metabolism to Improve Radiotherapy

Feb. 28-March 2, 2018
Big Sky, Montana

This workshop will convene basic science researchers who specialize in tumor metabolism, radiobiologists, radiologists, and radiation oncologists to explore the interface between tumor metabolism and radiotherapy response. The program is designed to allow for opportunities to network, collaborate, and engage in scientific discussions that focus on how best to leverage tumor-specific metabolic alterations to improve radiotherapy efficacy. Throughout the workshop, both preclinical and clinical studies will be discussed, with an emphasis on innovative bench to bedside approaches.

Registration for the workshop is now open, and AACR members in good standing (dues paid through Dec. 31, 2017) are eligible to register at the discounted, RRS member rate. Please visit the RRS web​site to learn more about the workshop, view the call for abstracts, and register to attend this exciting meeting!

FDA-AACR-ASTRO Regulatory Science and Policy Workshop: Clinical Development of Drug-radiotherapy Combinations

Feb. 22-23, 2018
Bethesda, Maryland

There is great interest among clinicians as well as regulatory authorities to address the lack of drug development for products intended specifically for use with radiation therapy. Emerging from the enthusiasm and momentum of a session at the AACR-sponsored Accelerating Anticancer Agent Development and Validation Workshop (May 3-5, 2017, Bethesda, Maryland), this two-day workshop will bring together regulatory agencies, industry, and academia to discuss the challenges in greater depth and come up with a path forward.

This workshop is supported in part by an educational grant from Bayer HealthCare Pharmaceuticals Inc. with additional support from AstraZeneca as well as the Cancer Research UK Combinations Alliance

Register for in-person or webcast participation.

Third AACR-SNMMI Joint Conference on State-of-the-Art Molecular Imaging in Cancer Biology and Therapy  

Feb. 14-17, 2018
Manchester Grand Hyatt
San Diego, California

This conference focused on cutting-edge research in molecular imaging research as applied to cancer biology and therapy.

AACR Special Conference: DNA Repair: Tumor Development and Therapeutic Response

Nov. 2-5, 2016
Hyatt Regency Montreal
Montreal, Quebec, Canada

Conference Co-chairpersons:
Robert G. Bristow, University Health Network Princess Margaret Hospital, Toronto, Ontario, Canada
Maria Jasin, Memorial Sloan Kettering Cancer Center, New York, New York
Theodore S. Lawrence, University of Michigan, Ann Arbor, Michigan